120 related articles for article (PubMed ID: 11872354)
21. Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients.
Hill BT; Scanlon KJ; Hansson J; Harstrick A; Pera M; Fichtinger-Schepman AM; Shellard SA
Eur J Cancer; 1994; 30A(6):832-7. PubMed ID: 7917544
[TBL] [Abstract][Full Text] [Related]
22. Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.
Walker MC; Parris CN; Masters JR
J Natl Cancer Inst; 1987 Aug; 79(2):213-6. PubMed ID: 3474453
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of telomerase activity with hTERT antisense increases the effect of CDDP-induced apoptosis in myeloid leukemia.
Yuan Z; Mei HD
Hematol J; 2002; 3(4):201-5. PubMed ID: 12189566
[TBL] [Abstract][Full Text] [Related]
24. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells.
Yamada K; Yajima T; Yagihashi A; Kobayashi D; Koyanagi Y; Asanuma K; Yamada M; Moriai R; Kameshima H; Watanabe N
Jpn J Cancer Res; 2000 Dec; 91(12):1278-84. PubMed ID: 11123427
[TBL] [Abstract][Full Text] [Related]
25. [Effect of inhibition of telomerase activity on cisplatin-induced apoptosis in K562 cells].
He D; Zhang H
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):355-8. PubMed ID: 11877097
[TBL] [Abstract][Full Text] [Related]
26. Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells.
Napier CE; Veas LA; Kan CY; Taylor LM; Yuan J; Wen VW; James A; O'Brien TA; Lock RB; MacKenzie KL
Biochim Biophys Acta; 2010 Oct; 1803(10):1142-53. PubMed ID: 20619302
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
28. Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro.
Akiyama M; Horiguchi-Yamada J; Saito S; Hoshi Y; Yamada O; Mizoguchi H; Yamada H
Eur J Cancer; 1999 Feb; 35(2):309-15. PubMed ID: 10448276
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
30. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo.
Lanvers-Kaminsky C; Winter B; Koling S; Frodermann B; Braun Y; Schaefer KL; Diallo R; Koenemann S; Wai D; Willich N; Poremba C; Schuck A
Oncol Rep; 2005 Sep; 14(3):751-8. PubMed ID: 16077987
[TBL] [Abstract][Full Text] [Related]
32. [Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes].
Zhdanov DD; Vasina DА; Orlova EV; Orlova VS; Pokrovsky VS; Pokrovskaya MV; Aleksandrova SS; Sokolov NN
Biomed Khim; 2017 Jan; 63(1):13-26. PubMed ID: 28251947
[TBL] [Abstract][Full Text] [Related]
33. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
Fu XH; Zhang JS; Zhang N; Zhang YD
World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
[TBL] [Abstract][Full Text] [Related]
34. Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents.
Smith V; Dai F; Spitz M; Peters GJ; Fiebig HH; Hussain A; Burger AM
J Chemother; 2009 Nov; 21(5):542-9. PubMed ID: 19933046
[TBL] [Abstract][Full Text] [Related]
35. Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells.
Biroccio A; Gabellini C; Amodei S; Benassi B; Del Bufalo D; Elli R; Antonelli A; D'Incalci M; Zupi G
Mol Pharmacol; 2003 Mar; 63(3):632-8. PubMed ID: 12606771
[TBL] [Abstract][Full Text] [Related]
36. Telomerase inhibition and telomere loss in BEL-7404 human hepatoma cells treated with doxorubicin.
Zhang RG; Guo LX; Wang XW; Xie H
World J Gastroenterol; 2002 Oct; 8(5):827-31. PubMed ID: 12378624
[TBL] [Abstract][Full Text] [Related]
37. Human telomerase reverse transcriptase (hTERT): a target molecule for the treatment of cisplatin-resistant tumors.
Park YP; Kim KD; Kang SH; Yoon DY; Park JW; Kim JW; Lee HG
Korean J Lab Med; 2008 Dec; 28(6):430-7. PubMed ID: 19127107
[TBL] [Abstract][Full Text] [Related]
38. Bovine seminal ribonuclease is cytotoxic for both malignant and normal telomerase-positive cells.
Viola M; Libra M; Callari D; Sinatra F; Spada D; Noto D; Emmanuele G; Romano F; Averna M; Pezzino FM; Stivala F; Travali S
Int J Oncol; 2005 Oct; 27(4):1071-7. PubMed ID: 16142325
[TBL] [Abstract][Full Text] [Related]
39. Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro.
Faraoni I; Turriziani M; Masci G; De Vecchis L; Shay JW; Bonmassar E; Graziani G
Clin Cancer Res; 1997 Apr; 3(4):579-85. PubMed ID: 9815723
[TBL] [Abstract][Full Text] [Related]
40. Telomerase activity, expression of Bcl-2 and cell cycle regulation in doxorubicin resistant gastric carcinoma cell lines.
Yoon KA; Ku JL; Yang JO; Park JG
Int J Mol Med; 2003 Mar; 11(3):343-8. PubMed ID: 12579337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
